Total Payments
$3,761
2024 Payments
$1,259
Companies
25
Transactions
218
Medicare Patients
29,035
Medicare Billing
$721,184
Payment Breakdown by Category
Food & Beverage$3,761 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,761 | 218 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,179 | 60 | $0 (2024) |
| Novo Nordisk Inc | $535.88 | 32 | $0 (2024) |
| Lilly USA, LLC | $419.69 | 31 | $0 (2024) |
| Abbott Laboratories | $393.43 | 27 | $0 (2024) |
| Amgen Inc. | $246.42 | 11 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $210.65 | 11 | $0 (2024) |
| Astellas Pharma US Inc | $112.38 | 8 | $0 (2024) |
| ABBVIE INC. | $100.86 | 5 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $72.49 | 5 | $0 (2024) |
| PFIZER INC. | $60.97 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,259 | 74 | GlaxoSmithKline, LLC. ($333.69) |
| 2023 | $1,165 | 70 | GlaxoSmithKline, LLC. ($475.40) |
| 2022 | $539.48 | 33 | Novo Nordisk Inc ($150.24) |
| 2021 | $74.39 | 5 | AstraZeneca Pharmaceuticals LP ($18.30) |
| 2020 | $36.11 | 2 | Gilead Sciences, Inc. ($36.11) |
| 2019 | $223.68 | 15 | Amgen Inc. ($45.16) |
| 2018 | $282.86 | 13 | GlaxoSmithKline, LLC. ($161.40) |
| 2017 | $180.34 | 6 | Amgen Inc. ($124.09) |
All Payment Transactions
218 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Neuromodulation | ||||||
| 12/31/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Neuromodulation | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: DIABETES | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Diabetes | ||||||
| 10/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Diabetes Care | ||||||
| 09/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $1.28 | General |
| Category: Neuromodulation | ||||||
| 09/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.78 | General |
| 09/06/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: VACCINE | ||||||
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Insomnia | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 5,900 | 7,928 | $462,060 | $151,108 |
| 2022 | 51 | 7,632 | 10,013 | $577,034 | $187,369 |
| 2021 | 54 | 8,190 | 10,656 | $641,196 | $204,660 |
| 2020 | 49 | 7,313 | 9,643 | $580,692 | $178,047 |
Total Patients
29,035
Total Services
38,240
Medicare Billing
$721,184
Procedure Codes
193
All Medicare Procedures & Services
193 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 269 | 441 | $77,175 | $39,184 | 50.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 149 | 149 | $10,795 | $10,393 | 96.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 179 | $25,060 | $10,181 | 40.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 413 | 601 | $43,873 | $7,874 | 17.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 392 | 462 | $45,276 | $7,605 | 16.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 421 | 667 | $36,018 | $6,894 | 19.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 431 | 768 | $12,288 | $6,435 | 52.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 331 | 331 | $9,930 | $6,226 | 62.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $6,175 | $5,336 | 86.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 148 | 148 | $5,180 | $4,575 | 88.3% |
| 82977 | Glutamyltransferase (liver enzyme) level | Office | 2023 | 406 | 624 | $18,720 | $4,393 | 23.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 133 | 138 | $16,560 | $3,980 | 24.0% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 420 | 650 | $16,250 | $3,838 | 23.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 396 | 500 | $18,000 | $3,798 | 21.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 21 | 21 | $8,295 | $3,476 | 41.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 337 | 344 | $26,832 | $3,016 | 11.2% |
| 84550 | Uric acid level, blood | Office | 2023 | 419 | 649 | $14,278 | $2,868 | 20.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 150 | 150 | $12,750 | $2,838 | 22.3% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 27 | $3,780 | $2,702 | 71.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 15 | $7,425 | $2,297 | 30.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 34 | 47 | $4,700 | $2,234 | 47.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 22 | 45 | $2,250 | $1,703 | 75.7% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 31 | $3,100 | $1,685 | 54.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 92 | 159 | $6,678 | $1,514 | 22.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 14 | 30 | $4,200 | $847.44 | 20.2% |
About Dr. Anthony Aventa, MD
Dr. Anthony Aventa, MD is a Specialist healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801875034.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Aventa, MD has received a total of $3,761 in payments from pharmaceutical and medical device companies, with $1,259 received in 2024. These payments were reported across 218 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,761).
As a Medicare-enrolled provider, Aventa has provided services to 29,035 Medicare beneficiaries, totaling 38,240 services with total Medicare billing of $721,184. Data is available for 4 years (2020–2023), covering 193 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Internal Medicine
- Location Austin, TX
- Active Since 01/16/2006
- Last Updated 06/13/2022
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1801875034
Products in Payments
- TRELEGY ELLIPTA (Drug) $858.19
- MOUNJARO (Drug) $268.30
- Rybelsus (Drug) $242.19
- JARDIANCE (Drug) $229.51
- FREESTYLE LIBRE 3 (Device) $199.96
- Repatha (Biological) $188.01
- SHINGRIX (Biological) $176.43
- Ozempic (Drug) $170.03
- PROCLAIM (Device) $116.11
- AREXVY (Drug) $99.32
- Wegovy (Drug) $94.10
- QUVIVIQ (Drug) $72.49
- VRAYLAR (Drug) $59.19
- Veozah (Drug) $56.62
- FREESTYLE LIBRE 2 (Device) $56.41
- BREO (Drug) $45.39
- EVENITY (Biological) $45.16
- ATRICLIP LAA EXCLUSION SYSTEM (Device) $44.55
- INJECTAFER (Drug) $41.21
- VOQUEZNA (Drug) $36.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Austin
Dr. Amin Al-Ahmad, Md, MD
Specialist — Payments: $1.0M
Specialist $1.0M
Dr. Steven Brotzman, M.d, M.D
Specialist — Payments: $962,398
Specialist $962,398
Dr. Thiru Lakshman, Md, MD
Specialist — Payments: $859,514
Specialist $859,514
Daniel Slaughter, M.d, M.D
Specialist — Payments: $151,066
Specialist $151,066
David Laverty, M.d, M.D
Specialist — Payments: $17,668
Specialist $17,668
Dr. Vivek Mahendru, Md, MD
Specialist — Payments: $15,260
Specialist $15,260